Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction-Reference-Cited by-同舟云学术

Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction

Published:2002-04 Issue:8 Volume:89 Page:930-936
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Mak Koon-Hou,Lee Lai-Heng,Wong Aaron,Chan Charles,Koh Tian-Hai,Lau Kean-Wah,Lim Yean-Leng

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Paradoxic elevation of fibrinopeptide A after streptokinase;Eisenberg;J Am Coll Cardiol,1987

2. Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator;Rapold;Circulation,1987

3. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction;Merlini;J Am Coll Cardiol,1987

4. Thrombin, generation inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin;Granger;J Am Coll Cardiol,1987

5. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction. Results from TIMI (Thrombolysis in Myocardial Infarction) 14;Coulter;Circulation,1987

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study;Atherosclerosis;2009-10

2. Systematic review of fibrinolytic-facilitated percutaneous coronary intervention: Potential benefits and future challenges;Canadian Journal of Cardiology;2009-03

3. Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test;Thrombosis and Haemostasis;2008

4. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis;Clinica Chimica Acta;2007-11

5. Benefits of transfer primary angioplasty are durable, so why are we waiting?;European Heart Journal;2007-02-28